Related Experiment Video
Updated: Jun 6, 2026
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies
1Department of Obstetrics and Gynecology, College of Medicine, University of Cincinnati, Cincinnati, OH, USA. rose.webster@uc.edu.
Insights
Preeclampsia, a pregnancy disorder, lacks a cure and is treated symptomatically. Studying the placental proteome may lead to early detection and targeted therapies for this serious condition.
Area of Science:
- Obstetrics and Gynecology
- Molecular Biology
- Biochemistry
Background:
- Preeclampsia is a serious pregnancy disorder causing elevated blood pressure and fetal abnormalities, leading to significant maternal and infant mortality.
- Current treatments for preeclampsia are symptomatic and lack definitive cures, highlighting the need for novel therapeutic strategies.
- Understanding the molecular basis of diseases like preeclampsia is crucial, with proteomics emerging as a key area of research.
Purpose of the Study:
- To explore the potential of proteomics in understanding the molecular underpinnings of preeclampsia.
- To investigate differences in protein expression patterns between normal and preeclamptic placentas.
- To assess the feasibility of using placental proteome analysis for early detection and targeted therapy of preeclampsia.
Main Methods:
- Proteomics enables the comprehensive identification of proteins expressed in a cell or organ.
- Analysis of protein expression patterns, including post-translational modifications (PTMs), can reveal disease-specific alterations.
- Comparative analysis of proteomes from normal versus preeclamptic placentas.
Main Results:
- The abstract does not contain specific results, but implies that differences in protein expression patterns were investigated.
- Proteomic analysis can identify proteins and PTMs relevant to disease states.
- The study sets the stage for future research into placental proteome differences.
Conclusions:
- Deciphering the placental proteome holds promise for advancing our understanding of preeclampsia.
- Identifying distinct protein expression profiles in preeclamptic placentas could pave the way for early diagnostic markers.
- Proteomic insights may enable the development of targeted therapeutic interventions for preeclampsia.
Abstract:
Preeclampsia, a disease of pregnancy, is a multisystem disorder associated with elevated maternal blood pressure, proteinurea, oedema, and fetal abnormalities. It is a major cause of mortality, morbidity, perinatal death, and premature delivery. Despite active research in the past decade, there is yet no definitive cure for preeclampsia. The disease has been treated symptomatically with antihypertensives, antieclamptics, bed rest, and a whole gamut of isolated therapies. In an attempt to understand the molecular basis of this disease and many other fatal diseases including cancer and heart disease, the scientific community has been turning to understanding the genome and more lately the "proteome". Proteomics enables researchers to identify all proteins expressed in a cell or organ and detect any PTM in the protein expression patterns. Deciphering the placental proteome and studying the differences in protein expression patterns in the normal as against the preeclamptic proteome might possibly in future lead to early detection and therapeutic targeting of preeclampsia.
